fortyseveninc.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Gilead Sciences, |
| Description | Inside the Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 165.160.13.20 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
fortyseveninc.com Valuation
|
US$4,599,684
Last updated: 2022-06-18 18:00:34
fortyseveninc.com has Semrush global rank of 2,301,094. fortyseveninc.com has an estimated worth of US$ 4,599,684, based on its estimated Ads revenue. fortyseveninc.com receives approximately 530,733 unique visitors each day. Its web server is located in United States, with IP address 165.160.13.20. According to SiteAdvisor, fortyseveninc.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,599,684 |
| Daily Ads Revenue | US$4,246 |
| Monthly Ads Revenue | US$127,376 |
| Yearly Ads Revenue | US$1,528,511 |
| Daily Unique Visitors | 35,383 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| fortyseveninc.com. | A | 7198 | IP: 165.160.13.20 |
| fortyseveninc.com. | A | 7198 | IP: 165.160.15.20 |
| fortyseveninc.com. | NS | 14400 | NS Record: dns2.cscdns.net. |
| fortyseveninc.com. | NS | 14400 | NS Record: dns1.cscdns.net. |
| fortyseveninc.com. | MX | 1800 | MX Record: 0 us-smtp-inbound-2.mimecast.com. |
| fortyseveninc.com. | MX | 1800 | MX Record: 0 us-smtp-inbound-1.mimecast.com. |
| fortyseveninc.com. | TXT | 3600 | TXT Record: 0597A55FA0 |
| fortyseveninc.com. | TXT | 3600 | TXT Record: MS=ms11383702 |
| fortyseveninc.com. | TXT | 3600 | TXT Record: v=spf1 a ip4:65.50.210.0/24 ip4:65.50.222.0/24 ip4:162.248.205.0/24 include:us._netblocks.mimecast.com include:mail.zendesk.com include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2022-06-18 18:00:34
| Medicine Questions Report an Adverse Event Investors Contact Global Operations North America Canada Mexico USA South America Argentina Brazil Asia China Hong Kong India Japan Korea Singapore Taiwan Middle East Saudi Arabia Israel Turkey United Arab Emirates Africa South Africa Australia Australia New Zealand Europe Austria Belgium Luxembourg Czech Republic & Slovakia Denmark Finland France Germany Greece Iceland Ireland Italy Netherlands Norway Poland & The Baltics Portugal Russia Spain Sweden Switzerland United Kingdom Our Purpose Mission and Core Values Partnerships and Community Inclusion and Diversity Corporate Giving Gilead Foundation Sustainability Advancing Global Health Medication Access About Leadership U.S. Locations How We Operate Ethics and Code of Conduct Science & Medicine Medicines Pipeline Research Clinical Trials News and Press Events Stories Newsroom Company Statements Annual Reports Careers Careers at Gilead Our Culture Meet Our Employees Inclusion and Diversity in |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Fri, 22 Oct 2021 15:58:30 GMT Location: http://www.gilead.com Content-Length: 0 X-ORACLE-DMS-ECID: f0902098-7418-4e36-8f71-a1cee2aedcd5-49a45481 X-ORACLE-DMS-RID: 0 HTTP/1.1 301 Moved Permanently Date: Fri, 22 Oct 2021 15:58:30 GMT Content-Type: text/html Content-Length: 195 Connection: keep-alive Location: https://www.gilead.com/ CF-Cache-Status: DYNAMIC Server: cloudflare CF-RAY: 6a23ed706ffe7ac8-MCI HTTP/2 200 date: Fri, 22 Oct 2021 15:58:31 GMT content-type: text/html; charset=utf-8 cache-control: no-cache, no-store pragma: no-cache expires: -1 vary: Accept-Encoding set-cookie: ASP.NET_SessionId=b25mccgq52ocryub1x5sof01; path=/; HttpOnly; SameSite=Lax set-cookie: ASP.NET_SessionId=b25mccgq52ocryub1x5sof01; path=/; HttpOnly; SameSite=Lax set-cookie: SC_ANALYTICS_GLOBAL_COOKIE=b3c9baef375e44d5be38f8c30bfb6cfe|False; expires=Mon, 20-Oct-2031 15:58:30 GMT; path=/; HttpOnly set-cookie: __RequestVerificationToken=FGjnBpXggR9XdmAvpY6BpLXyQ5d0PyQFBumw-OxGOR7TYwVBzA4jAvAOLjxMn8jfbqCrDFmzQRF8jvocA-_crxh3jAc1; path=/; HttpOnly x-frame-options: SAMEORIGIN x-frame-options: SAMEORIGIN request-context: appId=cid-v1:6768aa3e-6953-4f80-a634-cb45ec14a25d cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6a23ed721cf5fbac-MCI |
fortyseveninc.com Whois Information
Domain Name: FORTYSEVENINC.COM Registry Domain ID: 752306791_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2020-06-06T20:47:51Z Creation Date: 2007-01-12T19:03:35Z Registry Expiry Date: 2023-01-12T19:03:35Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.CSCDNS.NET Name Server: DNS2.CSCDNS.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-11T06:17:45Z <<< |